Switch theme
Sign up to access all valuation multiples
Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.
1988
3
Last FY Revenue $0K
Last FY EBITDA -$3.0M
$16.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Ludwig Enterprises achieved revenue of $0K and an EBITDA of -$3.0M.
Ludwig Enterprises expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ludwig Enterprises valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0K | XXX | XXX | XXX |
| Gross Profit | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | XXX | n/a | XXX | XXX | XXX |
| EBITDA | XXX | -$3.0M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -1373223% | XXX | XXX | XXX |
| EBIT | XXX | -$1.3M | XXX | XXX | XXX |
| EBIT Margin | XXX | -598244% | XXX | XXX | XXX |
| Net Profit | XXX | -$3.0M | XXX | XXX | XXX |
| Net Margin | XXX | -1390269% | XXX | XXX | XXX |
| Net Debt | XXX | $1.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Ludwig Enterprises's stock price is $0.
Ludwig Enterprises has current market cap of $14.8M, and EV of $16.8M.
See Ludwig Enterprises trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16.8M | $14.8M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Ludwig Enterprises has market cap of $14.8M and EV of $16.8M.
Ludwig Enterprises's trades at 77524.3x EV/Revenue multiple, and -5.6x EV/EBITDA.
Equity research analysts estimate Ludwig Enterprises's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ludwig Enterprises's P/E ratio is not available.
See valuation multiples for Ludwig Enterprises and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $14.8M | XXX | $14.8M | XXX | XXX | XXX |
| EV (current) | $16.8M | XXX | $16.8M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 77524.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -5.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -13.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -4.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -25.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLudwig Enterprises's revenue per employee in the last FY averaged $0K, while opex per employee averaged $0.4M for the same period.
Ludwig Enterprises's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ludwig Enterprises's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ludwig Enterprises and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -1373223% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 76323% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 598344% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Epigenomics | XXX | XXX | XXX | XXX | XXX | XXX |
| ToolGen | XXX | XXX | XXX | XXX | XXX | XXX |
| 4basebio | XXX | XXX | XXX | XXX | XXX | XXX |
| Genus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ludwig Enterprises acquired XXX companies to date.
Last acquisition by Ludwig Enterprises was XXXXXXXX, XXXXX XXXXX XXXXXX . Ludwig Enterprises acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ludwig Enterprises founded? | Ludwig Enterprises was founded in 1988. |
| Where is Ludwig Enterprises headquartered? | Ludwig Enterprises is headquartered in United States of America. |
| How many employees does Ludwig Enterprises have? | As of today, Ludwig Enterprises has 3 employees. |
| Is Ludwig Enterprises publicy listed? | Yes, Ludwig Enterprises is a public company listed on PINX. |
| What is the stock symbol of Ludwig Enterprises? | Ludwig Enterprises trades under LUDG ticker. |
| When did Ludwig Enterprises go public? | Ludwig Enterprises went public in 2007. |
| Who are competitors of Ludwig Enterprises? | Similar companies to Ludwig Enterprises include e.g. EZZ Life Science, Epigenomics, ToolGen, 4basebio. |
| What is the current market cap of Ludwig Enterprises? | Ludwig Enterprises's current market cap is $14.8M |
| Is Ludwig Enterprises profitable? | Yes, Ludwig Enterprises is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
